Current Progress in the Fatty Acid Metabolism in Cryptosporidium parvum1

Abstract Cryptosporidium parvum is one of the apicomplexans that can cause severe diarrhea in humans and animals. The slow development of anti-cryptosporidiosis chemotherapy is primarily due to the poor understanding on the basic metabolic pathways in this parasite. Many well-defined or promising drug targets found in other apicomplexans are either absent or highly divergent in C. parvum. The recently discovered apicoplast and its associated Type II fatty acid synthetic enzymes in Plasmodium, Toxoplasma, and Eimeria apicomplexans are absent in C. parvum, suggesting this parasite is unable to synthesize fatty acids de novo. However, C. parvum possesses a giant Type I fatty acid synthase (CpFAS1) that makes very long chain fatty acids using mediate or long chain fatty acids as precursors. Cryptosporidium also contains a Type I polyketide synthase (CpPKS1) that is probably involved in the production of unknown polyketide(s) from a fatty acid precursor. In addition to CpFAS1 and CpPKS1, a number of other enzymes involved in fatty acid metabolism have also been identified. These include a long chain fatty acyl elongase (LCE), a cytosolic acetyl-CoA carboxylase (ACCase), three acyl-CoA synthases (ACS), and an unusual “long-type” acyl-CoA binding protein (ACBP), which allows us to hypothetically reconstruct the highly streamlined fatty acid metabolism in this parasite. However, C. parvum lacks enzymes for the oxidation of fatty acids, indicating that fatty acids are not an energy source for this parasite. Since fatty acids are essential components of all biomembranes, molecular and functional studies on these critical enzymes would not only deepen our understanding on the basic metabolism in the parasites, but also point new directions for the drug discovery against C. parvum and other apicomplexan-based diseases.

[1]  S. Rawsthorne.  Carbon flux and fatty acid synthesis in plants. , 2002, Progress in lipid research.

[2]  M. J. LaGier,et al.  Mitochondrial-type iron-sulfur cluster biosynthesis genes (IscS and IscU) in the apicomplexan Cryptosporidium parvum. , 2003, Microbiology.

[3]  J. Barta,et al.  Cryptosporidium is more closely related to the gregarines than to coccidia as shown by phylogenetic analysis of apicomplexan parasites inferred using small-subunit ribosomal RNA gene sequences , 1999, Parasitology Research.

[4]  R. Fayer,et al.  General biology of Cryptosporidium. , 1990 .

[5]  M. Gardner,et al.  Functional characterization of the acyl carrier protein (PfACP) and beta-ketoacyl ACP synthase III (PfKASIII) from Plasmodium falciparum. , 2002, Molecular and biochemical parasitology.

[6]  S. Tzipori,et al.  The biology of Cryptosporidium. , 2000, Contributions to microbiology.

[7]  M. Jensen,et al.  Role of acylCoA binding protein in acylCoA transport, metabolism and cell signaling , 1999, Molecular and Cellular Biochemistry.

[8]  S. J. Upton,et al.  Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum. , 2000, Molecular and biochemical parasitology.

[9]  D. Toke,et al.  ELO2 and ELO3, Homologues of theSaccharomyces cerevisiae ELO1 Gene, Function in Fatty Acid Elongation and Are Required for Sphingolipid Formation* , 1997, The Journal of Biological Chemistry.

[10]  P. Okhuysen,et al.  CRYPTOSPORIDIOSIS , 1984, The Lancet.

[11]  J. Keithly,et al.  Cryptosporidium parvum Cpn60 targets a relict organelle , 2003, Current Genetics.

[12]  D. Sherman,et al.  Molecular genetics of polyketides and its comparison to fatty acid biosynthesis. , 1990, Annual review of genetics.

[13]  J. Palmer,et al.  A Plastid of Probable Green Algal Origin in Apicomplexan Parasites , 1997, Science.

[14]  T. Kaneda,et al.  Type selective inhibition of microbial fatty acid synthases by thiolactomycin , 2004, Archives of Microbiology.

[15]  R. Haselkorn,et al.  Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Rawlings,et al.  Biosynthesis of polyketides. , 1997, Natural product reports.

[17]  P. Black,et al.  Mutational Analysis of a Fatty Acyl-Coenzyme A Synthetase Signature Motif Identifies Seven Amino Acid Residues That Modulate Fatty Acid Substrate Specificity* , 1997, The Journal of Biological Chemistry.

[18]  A. Alcina,et al.  The Plasmodium falciparum fatty acyl-CoA synthetase family (PfACS) and differential stage-specific expression in infected erythrocytes. , 2003, Molecular and biochemical parasitology.

[19]  Ping Xu,et al.  Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum , 2004, Science.

[20]  M. Jensen,et al.  Role of acyl-CoA binding protein in acyl-CoA metabolism and acyl-CoA-mediated cell signaling. , 2000, The Journal of nutrition.

[21]  P. Tonge,et al.  Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs. , 2003, Biochemistry.

[22]  J. Warrington,et al.  Identification of a Mammalian Long Chain Fatty Acyl Elongase Regulated by Sterol Regulatory Element-binding Proteins* , 2001, The Journal of Biological Chemistry.

[23]  P. Okhuysen,et al.  Cryptosporidium virulence determinants--are we there yet? , 2002, International journal for parasitology.

[24]  R. Haselkorn,et al.  The Carboxyltransferase Activity of the Apicoplast Acetyl-CoA Carboxylase of Toxoplasma gondii Is the Target of Aryloxyphenoxypropionate Inhibitors* , 2002, The Journal of Biological Chemistry.

[25]  David Alland,et al.  Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase , 2003, Journal of Biological Chemistry.

[26]  H. Sone,et al.  Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. , 2002, Journal of lipid research.

[27]  R. Heath,et al.  Broad Spectrum Antimicrobial Biocides Target the FabI Component of Fatty Acid Synthesis* , 1998, The Journal of Biological Chemistry.

[28]  D W Rice,et al.  Mechanism of action of diazaborines. , 1998, Biochemical pharmacology.

[29]  D. Roos,et al.  Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Toke,et al.  Isolation and Characterization of a Gene Affecting Fatty Acid Elongation in Saccharomyces cerevisiae* , 1996, The Journal of Biological Chemistry.

[31]  N. Surolia,et al.  Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum , 2001, Nature Medicine.

[32]  K. Nagai,et al.  Direct evidence for cyanide-insensitive quinol oxidase (alternative oxidase) in apicomplexan parasite Cryptosporidium parvum: phylogenetic and therapeutic implications. , 2004, Biochemical and biophysical research communications.

[33]  R. Wilson,et al.  Progress with parasite plastids. , 2002, Journal of molecular biology.

[34]  M. Chye,et al.  Isolation of a gene encoding Arabidopsis membrane-associated acyl-CoA binding protein and immunolocalization of its gene product. , 1999, The Plant journal : for cell and molecular biology.

[35]  M. Chye,et al.  Single amino acid substitutions at the acyl-CoA-binding domain interrupt 14[C]palmitoyl-CoA binding of ACBP2, an Arabidopsis acyl-CoA-binding protein with ankyrin repeats , 2000, Plant Molecular Biology.

[36]  H. Philippe,et al.  What is the phylogenetic position of Cryptosporidium? , 2000, International journal of systematic and evolutionary microbiology.

[37]  S. Ralph,et al.  A Type II Pathway for Fatty Acid Biosynthesis Presents Drug Targets in Plasmodium falciparum , 2003, Antimicrobial Agents and Chemotherapy.

[38]  M. Chye.  Arabidopsis cDNA encoding a membrane-associated protein with an acyl-CoA binding domain , 1998, Plant Molecular Biology.

[39]  D. Rice,et al.  Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. , 2003, Molecular and biochemical parasitology.

[40]  G. McFadden,et al.  The apicoplast: a plastid in Plasmodium falciparum and other Apicomplexan parasites. , 2003, International review of cytology.

[41]  R. Lyons,et al.  Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. , 2001, International journal for parasitology.

[42]  R J Heath,et al.  Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis* , 1999, The Journal of Biological Chemistry.

[43]  Stuart Smith.  The animal fatty acid synthase: one gene, one polypeptide, seven enzymes , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  M. J. LaGier,et al.  Cryptosporidium parvum: the first protist known to encode a putative polyketide synthase. , 2002, Gene.

[45]  C. Janson,et al.  Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents. , 2001, Bioorganic & medicinal chemistry letters.

[46]  A. Alcina,et al.  The cloning and expression of Pfacs1, a Plasmodium falciparum fatty acyl coenzyme A synthetase-1 targeted to the host erythrocyte cytoplasm. , 1999, Journal of molecular biology.

[47]  J. Keithly,et al.  Expression and functional characterization of a giant Type I fatty acid synthase (CpFAS1) gene from Cryptosporidium parvum. , 2004, Molecular and biochemical parasitology.

[48]  Jessica C Kissinger,et al.  Mining the Plasmodium genome database to define organellar function: what does the apicoplast do? , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[49]  Colin Berry,et al.  Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents. , 2004, Bioorganic & medicinal chemistry.

[50]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[51]  E. Entrala,et al.  Glycolytic enzyme activities in Cryptosporidium parvum oocysts. , 1997, FEMS microbiology letters.

[52]  P. Gornicki.  Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites. , 2003, International journal for parasitology.

[53]  R. Haselkorn,et al.  Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Keithly,et al.  Cryptosporidium parvum appears to lack a plastid genome. , 2000, Microbiology.

[55]  C. Roberts,et al.  Comparison of the phosphofructokinase and pyruvate kinase activities of Cryptosporidium parvum, Eimeria tenella and Toxoplasma gondii. , 1996, Molecular and biochemical parasitology.